Celldex Therapeutics, Inc. (CLDX) by event type
CLDX moves most on analyst upgrades — a median of -1.15% at 30 minutes across 10 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the CLDX overview →
How CLDX reacts across 5 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 2,634 of 2,717 | 10 | -1.15% | 30% | -1.07% |
| Coverage initiations 729 of 2,283 | 30 | +0.20% | 53% | +0.39% |
| Rating reiterations 938 of 3,522 | 88 | +0.08% | 53% | +0.37% |
| Price-target raises 582 of 1,790 | 13 | +0.06% | 54% | -0.20% |
| Price-target cuts 56 of 1,527 | 14 | +0.46% | 64% | -1.42% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 1 further class was observed with fewer than 10 measured events and is not published.
That’s how CLDX usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Coverage initiations → · Rating reiterations → · Price-target raises → · Price-target cuts → · CLDX overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | 257 | -0.63% | 42% |
| Addus HomeCare Corporation (ADUS) | 256 | -0.02% | 47% |
| Prothena Corporation plc - Ordinary Shares (PRTA) | 256 | -0.04% | 49% |
| Xeris Biopharma Holdings, Inc. (XERS) | 256 | +0.32% | 57% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.